Medtech Europe’s John Brennan: What’s Ahead For Industry In Implementing The EU Regulations?
What help is there out there for companies to understand how to go about implementing the EU’s future Medical Device and IVD Regulations? John Brennan of device trade association Medtech Europe reassures industry that a plan of action is in place and that the sector's voice will be heard by policy-makers during this complicated period of transition in this Q&A with Medtech Insight.
You may also be interested in...
EU power players are currently negotiating vast changes to how in vitro diagnostics are regulated in Europe. The resulting system will involve a lot more external oversight than today for most IVDs. Here's a rundown of what to expect.
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.